EE540 Cost-Effectiveness of Next Generation Sequencing to Select Microsatellite Stable/Mismatch Repair Proficient Metastatic Colorectal Cancer Patients for Immune Checkpoint Inhibitor Therapy.
Saved in:
| Title: | EE540 Cost-Effectiveness of Next Generation Sequencing to Select Microsatellite Stable/Mismatch Repair Proficient Metastatic Colorectal Cancer Patients for Immune Checkpoint Inhibitor Therapy. |
|---|---|
| Authors: | Geisler, B1 (AUTHOR), Meltzer, S2 (AUTHOR), Burger, EA3 (AUTHOR), Ree, AH2 (AUTHOR), Aas, E3 (AUTHOR) |
| Source: | Value in Health. 2024 Supplement, Vol. 27 Issue 12, pS161-S162. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 10983015 |
|---|---|
| DOI: | 10.1016/j.jval.2024.10.820 |
